Chinese robotics firm Unitree is gearing up for a new capital injection, eyeing a valuation between 10 billion and 15 billion yuan (roughly US$1.4 billion to US$2.1 billion). The company’s recent restructuring—from a limited liability setup to a joint-stock model—paves the way for share issuance and smoother capital flow, setting the stage for a potential IPO on China’s stock markets.
In conversations with its partners, Unitree hinted that this shift was designed to better tackle its growing development needs. Although the firm has remained tight-lipped about the finer points of its investment strategy, this move clearly aligns with broader trends in the Chinese robotics sector, where innovation in humanoid robotics is intensifying. If you’re watching the tech space closely, Unitree’s actions offer a telling sign of how established companies are preparing to capitalise on emerging opportunities.
